The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients

Transplantation

Volumn 75, Issue 11, 2003, Pages 1858-1864

  Helanterä, Ilkka ^a   Koskinen, Petri ^a   Törnroth, Tom ^a   Loginov, Raisa ^a   Grönhagen Riska, Carola ^a   Lautenschlager, Irmeli ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IN SITU HYBRIDIZATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; REPERFUSION INJURY; VASCULARIZATION;

ADULT; ARTERIOLES; BIOPSY; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL CIRCULATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0038384672     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000064709.20841.E1     Document Type: Article

References (30)

1. Schweitzer EJ, Matas AJ, Gillingham KJ, et al. Causes of renal allograft loss: Progress in the 1980s, challenges for the 1990s. Ann Surg 1991; 214(6): 679.
2. Paul LC. Chronic allograft nephropathy: An update. Kidney Int 1999; 56(3): 783.
3. Lindholm A, Ohlman S, Albrechtsen D, et al. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56(2): 307.
4. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66(12): 1697.
5. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338(24): 1741.
6. Pouteil-Noble C, Ecochard R, Landrivon G, et al. Cytomegalovirus infection: An etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 1993; 55(4): 851.
7. Reinke P, Fietze E, Ode-Hakim S, et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344(8939-8940):1737.
8. Dickenmann MJ, Cathomas G, Steiger J, et al. Cytomegalovirus infection and graft rejection in renal transplantation. Transplantation 2001; 71(6): 764.
9. Grattan MT, Moreno-Cabral CE, Starnes VA, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261(24): 3561.
10. Koskinen PK, Nieminen MS, Krogerus LA, et al. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 1993; 12(5): 724.
11. Kroshus TJ, Kshettry VR, Savik K, et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997; 114(2): 195.
12. Arnold JC, Portmann BC, O'Grady JG, et al. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology 1992; 16(2): 285.
13. Lautenschlager I, Hockerstedt K, Jalanko H, et al. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 1997; 25(1): 190.
14. Lautenschlager I, Soots A, Krogerus L, et al. Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat. Transplantation 1997; 64(3): 391.
15. Lemstrom KB, Bruning JH, Bruggeman CA, et al. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993; 92(2): 549.
16. Martelius T, Krogerus L, Hockerstedt K, et al. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liover allografts. Hepatology 1998; 27(4): 996.
17. Yilmaz S, Koskinen PK, Kallio E, et al. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int 1996; 50(2): 526.
18. Lautenschlager I, Soots A, Krogerus L, et al. Time-related effects of cytomegalovirus infection on the development of chronic renal allograft rejection in a rat model. Intervirology 1999; 42(5-6): 279.
19. Kloover JS, Soots AP, Krogerus LA, et al. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft. Transplantation 2000; 69(12): 2641.
20. The TH, van den Berg AP, Harmsen MC, et al. The cytomegalovirus antigenemia assay: A plea for standardization. Scand J Infect Dis Suppl 1995; 99: 25.
21. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55(2): 713.
22. Baboolal K, Jones GA, Janezic A, et al. Molecular and structural consequences of early renal allograft injury. Kidney Int 2002; 61(2): 686.
23. Seron D, Moreso F, Fulladosa X, et al. Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int 2002; 61(2): 727.
24. Rush D, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998; 9(11): 2129.
25. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients: Clinico-pathological correlations using the Banff schema. Transplantation 1995; 59(4): 511.
26. Holma K, Tornroth T, Gronhagen-Riska C, et al. Expression of the cytomegalovirus genome in kidney allografts during active and latent infection. Transpl Int 2000; 13(suppl 1): S363.
27. Iwamoto GK, Monick MM, Clark BD, et al. Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest 1990; 85(6): 1853.
28. Smith PD, Saini SS, Raffeld M, et al. Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. J Clin Invest 1992; 90(5): 1642.
29. Fietze E, Prosch S, Reinke P, et al. Cytomegalovirus infection in transplant recipients: The role of tumor necrosis factor. Transplantation 1994; 58(6): 675.
30. Michelson S, Alcami J, Kim SJ, et al. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J Virol 1994; 68(9): 5730.